0001209191-20-048062.txt : 20200824
0001209191-20-048062.hdr.sgml : 20200824
20200824160057
ACCESSION NUMBER: 0001209191-20-048062
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200820
FILED AS OF DATE: 20200824
DATE AS OF CHANGE: 20200824
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hoerter Steven L.
CENTRAL INDEX KEY: 0001533451
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38219
FILM NUMBER: 201127862
MAIL ADDRESS:
STREET 1: 2525 28TH STREET, SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Deciphera Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001654151
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200299725
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 SMITH STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-209-6400
MAIL ADDRESS:
STREET 1: 200 SMITH STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Deciphera Pharmaceuticals, LLC
DATE OF NAME CHANGE: 20150928
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-08-20
0
0001654151
Deciphera Pharmaceuticals, Inc.
DCPH
0001533451
Hoerter Steven L.
C/O DECIPHERA PHARMACEUTICALS, INC.
200 SMITH STREET
WALTHAM
MA
02451
1
1
0
0
President and CEO
Common Stock
2020-08-20
4
M
0
187
25.40
A
42767
D
Stock Option (Right to Buy)
25.40
2020-08-20
4
M
0
187
0.00
D
2029-03-17
Common Stock
187
396813
D
This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan. 25% of the options vested on March 18, 2020, and the remaining options shall vest in equal monthly installments over the following three years, subject to continued service through such dates.
/s/ Jeffrey Held, Attorney-in-Fact
2020-08-24